CLOs on the Move

Medtronic

www.medtronic.com

 
Medtronic, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic`s mission is: To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life. To direct our growth in the areas of biomedical engineering where we display maximum strength and ability; to gather people and facilities that tend to augment these areas; to continuously build on these areas through education and knowledge assimilation; to avoid participation in areas where ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.medtronic.com
  • 710 Medtronic Parkway
    Minneapolis, MN USA 55432
  • Phone: 763.514.4000

Executives

Name Title Contact Details
Gary Corona
EVP, Chief Financial Officer Profile
Thierry Pieton
Chief Financial Officer Profile
Yarmela Pavlovic
Chief regulatory officer Profile
Sally Gardinier
Canada Compliance Officer Profile
Robert Ernest
Legal Director, Global Operations and Supply Profile

Similar Companies

CommonHealth

CommonHealth comprises Altum, Carbon, CommonHealth London, CommonHealth Paris, Conectics, Earthborn, EvoLogue, Ferguson, HLS, MBS/Vox, ProCom, Qi, Solara and Valos.

Bionix Development

Bionix Medical Technologies has provided medical professionals with innovative medical devices since 1984. Bionix is proud to offer cerumen removal, wound care, feeding tube care, infant feeding, bolus control and nasal visualization products.

Cvrx

CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.

Valeritas

Valeritas is committed to developing and commercializing innovative treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 diabetes. Valeritas` portfolio is headlined by the V-Go® disposable insulin delivery device, which is being commercialized and reimbursed in a specialty pharmaceutical model and is distributed through retail pharmacy.

E-Way International

E-Way International is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.